🇺🇸 FDA
Patent

US 8148378

Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

granted A61KA61K31/00A61K31/501

Quick answer

US patent 8148378 (Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal) held by Xenon Pharmaceuticals Inc. expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/00, A61K31/501, A61K31/551, A61P